This is dramatically manifest in thrombotic thrombocytopenic purpura, a condition of genetic or acquired deficiency for the protease that cleaves the endothelium-derived platelet binder von Willebrand factor (51). This evidence concerns the gene VWF and thrombotic thrombocytopenic purpura.